Neurogene (NGNE) Other Non-Current Liabilities (2013 - 2025)
Neurogene (NGNE) posted Other Non-Current Liabilities of $51000.0 for Q4 2025, little changed on a QoQ basis from $51000.0 in Q3 2025, and down 92.9% year-over-year from $718000.0 in Q4 2024.
Neurogene (NGNE) Other Non-Current Liabilities (2013 - 2025) Analysis & Trends
Neurogene's Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $51000.0 for Q4 2025.
- Quarterly Other Non-Current Liabilities fell 92.9% year-over-year to $51000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $51000.0 (down 92.9% YoY) and the FY2025 annual result came in at $51000.0, down 92.9% from the prior year.
- Other Non-Current Liabilities was $51000.0 for Q4 2025 at Neurogene, roughly flat from $51000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $718000.0 in Q4 2024 and bottomed at $51000.0 in Q2 2024.
- A 3-year average of $158888.9 and a median of $51000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Other Non-Current Liabilities surged 253.69% — and 2025, when it tumbled 92.9%.
- Neurogene's Other Non-Current Liabilities stood at $203000.0 in 2023, then jumped by 253.69% to $718000.0 in 2024, then tumbled by 92.9% to $51000.0 in 2025.
- Business Quant data shows NGNE's Other Non-Current Liabilities at $51000.0 in Q4 2025, $51000.0 in Q3 2025, and $51000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 718,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 203,000.00 |
| Dec 31, 2023 | 203,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Dec 31, 2018 | 319,000.00 |
| Sep 30, 2018 | 343,000.00 |
| Jun 30, 2018 | 401,000.00 |
| Mar 31, 2018 | 443,000.00 |
| Dec 31, 2017 | 486,000.00 |
| Sep 30, 2017 | 513,000.00 |
| Jun 30, 2017 | 548,000.00 |
| Mar 31, 2017 | 562,000.00 |
| Dec 31, 2016 | 197,000.00 |